Becoming a mom may be emotionally taxing for some, and mental well-being during the perinatal period is associated with six modifiable lifestyle risk factors, namely diet quality, vitamin D concentrations, smoking, physical activity, sleep quality, and the presence of emotional support, according to data from a Singapore cohort study.
Clinicians from the Faculty of Medicine at the Chinese University of Hong Kong (CUHK) have developed a modified high-intensity–focused ultrasound (HIFU) treatment with oxytocin augmentation for uterine fibroids, which produced 100 percent symptom resolution in nine consecutive patients.
The dual orexin receptor antagonist suvorexant was effective in managing VMS*-associated insomnia among women in midlife, with further benefits for self-reported night-time, but not daytime, VMS, according to data presented at NAMS 2020.
Use of the self-administered TX-004HR – an applicator-free, ultra-low-dose, 17β-oestradiol softgel vaginal insert – led to significant improvements in the symptoms of vulvovaginal atrophy (VVA) such as moderate-to-severe dyspareunia and vaginal dryness in postmenopausal women aged >60 years, according to updated results from the phase III REJOICE trial presented at NAMS 2020.
One way how hormone therapy with oestradiol may slow the progression of atherosclerotic cardiovascular disease (CVD) in postmenopausal women is through the reduction of inflammatory biomarkers, according to the ELITE* study presented at the NAMS 2020 Annual Meeting.
Levels of depression, anxiety, and stress among antenatal women increase due to a lack of timely and reliable information on the impact of the novel coronavirus disease (COVID-19) on pregnancy and its outcomes, according to a Singapore study.
Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.